Reduced indinavir exposure during pregnancy

Reduced indinavir exposure during pregnancy

Aim: To describe the pharmacokinetics and safety of indinavir boosted with ritonavir (IDV/r) during the second and third trimesters of pregnancy and in the post-partum period. Methods: IMPAACT P1026s is an on-going, prospective, non-blinded study of antiretroviral pharmacokinetics (PK) in HIV-infect...

Saved in:

書目詳細資料
Main Authors:	Tim R. Cressey, Brookie M. Best, Jullapong Achalapong, Alice Stek, Jiajia Wang, Nantasak Chotivanich, Prapap Yuthavisuthi, Pornnapa Suriyachai, Sinart Prommas, David E. Shapiro, D. Heather Watts, Elizabeth Smith, Edmund Capparelli, Regis Kreitchmann, Mark Mirochnick
格式:	雜誌
出版:	2018
主題:	Medicine Pharmacology, Toxicology and Pharmaceutics
在線閱讀:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84882644760&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/52824
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	Chiang Mai University

相似書籍

Reduced indinavir exposure during pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Efavirenz pharmacokinetics during pregnancy and infant washout
由: Regis Kreitchmann, et al.
出版: (2019)

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
由: Tim R. Cressey, et al.
出版: (2018)

Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
由: Tim R. Cressey, et al.
出版: (2018)

Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
由: Tim R. Cressey, et al.
出版: (2018)

Raltegravir pharmacokinetics during pregnancy
由: D. Heather Watts, et al.
出版: (2018)

Raltegravir pharmacokinetics during pregnancy
由: D. Heather Watts, et al.
出版: (2018)

Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women
由: Alice Stek, et al.
出版: (2018)

Pharmacokinetics of once versus twice daily darunavir in pregnant HIV-infected women
由: Alice Stek, et al.
出版: (2018)

Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy
由: Regis Kreitchmann, et al.
出版: (2018)

Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy
由: Regis Kreitchmann, et al.
出版: (2018)

Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected thai patients receiving indinavir boosted with ritonavir
由: Cressey T.R., et al.
出版: (2014)

Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected thai patients receiving indinavir boosted with ritonavir
由: Tim R. Cressey, et al.
出版: (2018)

Bioequivalence of indinavir capsules in healthy volunteers
由: Suvatna Chulavatnatol, et al.
出版: (2018)

Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
由: Cressey T., et al.
出版: (2017)

A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine
由: Russell B. Van Dyke, et al.
出版: (2018)

A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine
由: Russell B. Van Dyke, et al.
出版: (2018)

Indinavir/ritonavir remains an important component of HAART for the treatment of HIV/AIDS, particularly in resource-limited settings
由: Tim R. Cressey, et al.
出版: (2018)

Indinavir/ritonavir remains an important component of HAART for the treatment of HIV/AIDS, particularly in resource-limited settings
由: Tim R. Cressey, et al.
出版: (2018)

Efficacy and plasma concentrations of indinavir when boosted with ritonavir in human immunodeficiency virus-infected Thai children
由: Nottasorn Plipat, et al.
出版: (2018)

Single dose cefazolin for abdominal hysterectomy prophylaxis
由: Sinart Prommas
出版: (2009)

Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
由: Cressey T.R., et al.
出版: (2014)

Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy
由: Tim R. Cressey, et al.
出版: (2018)

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy
由: Ahizechukwu C. Eke, et al.
出版: (2020)

A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine
由: Van Dyke R., et al.
出版: (2017)

Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine
由: Pedro Cahn, et al.
出版: (2018)

Tenofovir versus placebo to prevent perinatal transmission of hepatitis B
由: Gonzague Jourdain, et al.
出版: (2018)

Hydronephrosis after radical hysterectomy: A prospective study
由: Prapaporn Suprasert, et al.
出版: (2018)

Hydronephrosis after radical hysterectomy: A prospective study
由: Prapaporn Suprasert, et al.
出版: (2018)

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV
由: Ahizechukwu C. Eke, et al.
出版: (2020)

Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling
由: Stein Schalkwijk, et al.
出版: (2019)

Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: Results of a 48-week open-label, equivalence trial (CNA3014)
由: Asda Vibhagool, et al.
出版: (2018)

Prevention of mother-to-child transmission of hepatitis B virus: A phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
由: Gonzague Jourdain, et al.
出版: (2018)

Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations
由: Diana F. Clarke, et al.
出版: (2018)

Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations
由: Diana F. Clarke, et al.
出版: (2018)

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
由: Stein Schalkwijk, et al.
出版: (2018)

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
由: Stein Schalkwijk, et al.
出版: (2018)

Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus
由: Tim R. Cressey, et al.
出版: (2018)

Developmental pharmacokinetic changes of lamivudine in infants and children
由: Adriana H. Tremoulet, et al.
出版: (2018)